Breast cancer AI firm Volpara sees strong cash receipts

Breast cancer AI firm Volpara sees strong cash receipts
Rebecca Howard
ASX-listed Volpara Health Technologies collected its highest quarterly cash receipts since listing in 2016. Wellington-based Volpara, which focuses on early detection of breast cancer using artificial intelligence, said it received nearly $5.0 million in the first quarter to June 20, up 112 percent on the year.  It was the fourth straight quarter with cash receipts over $4.5 million. “Q1 saw the emergence of covid-19, but we’re very heartened by the strong cash receipts, negligible churn, and the fact that we got a significant number of n...

More Listed Companies

UPDATE: NZX directors mauled in fee vote
Markets

UPDATE: NZX directors mauled in fee vote

Of shares voted on the re-election of NZX chair John McMahon, 27.62% were opposed.

How ‘shareholder value’ became a Wall Street mantra
Policy

How ‘shareholder value’ became a Wall Street mantra

Michael Jensen inspired the transformation of capitalism. Was he a hero or a villain?

Bloomberg 13 Apr 2024
How many boards should a director sit on?
Listed Companies

Simon Robertson: How many boards should a director sit on?

An attempt to judge the composition trends in NZX boards is challenging.

Simon Robertson 13 Apr 2024
Wellington council picks Precinct for major civic square project
Property

Wellington council picks Precinct for major civic square project

Firm will fund and build the new five-star green building.

Staff reporters 11 Apr 2024